Class will soon be in session at the Allergan Aesthetics headquarters. The AbbVie brand plans to open doors at its ...

Allergan – which is set to be acquired by AbbVie in a $63 billion deal announced ... that it had implemented a recall of textured breast implants “in certain international markets.” ...

Companies such as Allergan (AbbVie), Revance Therapeutics ... Galderma launched Radiesse (+) Lidocaine injectable implants, specifically designed for deep injection (subdermal and supraperiosteal ...

Good day, and welcome to the Fourth Quarter 2024 Harvard Bioscience Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a ...

2015 saw many advances in 3-D printing in the world of medicine, with rigid medical devices such as hearing aids, dental implants and ... BMS and AbbVie's Empliciti (elotuzumab) was the last ...

AbbVie Inc. (NYSE:ABBV) entered the obesity race last week when it in-licensed GUB014295 (also called GUBamy) from Denmark-based Gubra. The candidate is a long-acting amylin analog for the ...

AbbVie is navigating significant shareholder activism as it urges opposition to two governance proposals ahead of its May 2025 meeting, fostering investor attention. Despite reporting a Q4 net ...

AbbVie’s former CEO Richard Gonzalez—who collected a $25.7 million payout for his final full year on the job in 2023—often ranked among the industry’s highest-paid CEOs during his tenure ...

Whales with a lot of money to spend have taken a noticeably bullish stance on AbbVie. Looking at options history for AbbVie ABBV we detected 29 trades. If we consider the specifics of each trade ...

AbbVie’s immunology blockbusters Rinvoq and Skyrizi took the first and second slots, respectively, for the month, resuming the custom they upheld throughout most of 2024. Those gains over ...

AbbVie has signed a licensing deal with Danish-based Gubra to develop an obesity drug, marking the North Chicago company's first foray into the obesity market. Gubra will receive $350 million ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other stocks. Some of the major U.S. indexes began recovering on Wednesday, following the Trump ...